Predictions
HCA Holdings Inc.
Start price
Target price
Perf. (%)
€290.50
29.04.24
29.04.24
€341.93
29.04.25
29.04.25
0.00%
29.04.24
29.04.24
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€4.28
29.04.24
29.04.24
€5.00
31.07.26
31.07.26
-2.92%
29.04.24
29.04.24
Could be very worthwhile Investment >20% year
Viking Therapeutics Inc
Start price
Target price
Perf. (%)
€69.50
29.04.24
29.04.24
€100.00
31.03.26
31.03.26
1.24%
29.04.24
29.04.24
Could be very worthwhile Investment >20% year
ImmunityBio Inc.
Start price
Target price
Perf. (%)
€7.90
29.04.24
29.04.24
€10.00
31.01.26
31.01.26
6.05%
29.04.24
29.04.24
Could be very worthwhile Investment >20% year
HCA Holdings Inc.
Start price
Target price
Perf. (%)
€290.50
29.04.24
29.04.24
€307.19
29.04.25
29.04.25
0.00%
29.04.24
29.04.24
Adverum Biotechnologies Inc.
Start price
Target price
Perf. (%)
€1.38
29.04.24
29.04.24
€20.55
29.04.25
29.04.25
-
20.03.24
20.03.24
HCA Holdings Inc.
Start price
Target price
Perf. (%)
€287.80
29.04.24
29.04.24
€322.23
29.04.25
29.04.25
0.94%
29.04.24
29.04.24
Viking Therapeutics Inc
Start price
Target price
Perf. (%)
€69.80
29.04.24
29.04.24
€100.00
29.04.25
29.04.25
0.80%
29.04.24
29.04.24
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€3.76
28.04.24
28.04.24
€10.00
25.03.25
25.03.25
10.37%
29.04.24
29.04.24
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€3.96
28.04.24
28.04.24
-
28.04.25
28.04.25
0.43%
29.04.24
29.04.24
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€1.83
28.04.24
28.04.24
-
28.04.25
28.04.25
1.69%
29.04.24
29.04.24
Biogen Inc.
Start price
Target price
Perf. (%)
€194.35
28.04.24
28.04.24
-
28.04.25
28.04.25
3.47%
29.04.24
29.04.24
Bad rating
EBIT decline/stagnation expected
Probably not worthwhile Investment
High valuation